TY  - JOUR

T1  - Critical appraisal of axitinib in the treatment of advanced renal cell carcinoma.

JO  - Biologics: Targets and Therapy

UR  - https://eprints.whiterose.ac.uk/id/eprint/145610

PY  - 2013/02/28

AU  - Ansari J

AU  - Hussain SA

AU  - Ansari A

AU  - Glaholm J

ED  - 

DO  - DOI: 10.2147/BTT.S25862

PB  - Dove Medical Press

VL  - 7

SP  - 39

EP  - 46

Y2  - 2025/12/05

ER  -